Subscribe


PD breaking news – Actavis to exit Australian generics

Allergan Australia and New Zealand acquisition completed. 

Actavis has confirmed it will exit the Australian generics business, as part of the completed acquisition of Allergan Australia and New Zealand.

This included the generic hospital, generic pharmaceutical, Pierre Fabre and Medico businesses.

“In the interim, Actavis will continue to supply the Australian market with high quality generic medicines through its current distribution channels while alternative distribution models are actively explored.”

The Actavis New Zealand generic market would continue with no change.

Actavis would also seek shareholder approval to change its name to Allergan in May or June, although the Actavis name could continue to be used for certain regions and products, Allergan said.

Allergan ANZ vice president and md Glen Curran said it was “very much business as usual” and in the short term, the company was working to integrate the companies smoothly.

“During this process we are committed to keeping all of our customers informed of our progress.”

The combined company would offer an expanded portfolio of innovator products, Allergan said.

Curran said about $1.7b would be invested globally in R&D this year.

For more, see tomorrow’s Pharmacy Daily.


The above Breaking News Alert was sent to Pharmacy Daily subscribers on 25 Mar 15

Make a comment...



Established in 2007, Pharmacy Daily is Australia's leading pharmacy industry publication, and is sent as a free subscription to people across the industry as a PDF newsletter every weekday.

Register for Pharmacy Daily trial subscription

To sign up for a free subscription, click on the button at right.

Click here to see a sample issue of Pharmacy Daily.

Click here for more information on subscriptions.

Alternatively, you can search our site via the search box on the right hand side of the page, or find other content below.

Recent Pharmacy Daily articles

22 Nov

Clear Shave Gel by Milkman - MILKMAN Grooming Co has redefined what it ...


22 Nov

ChapStick Core Range from Pfizer - GET your lips summer-ready with ChapStick's timeless ...


22 Nov

Zostrix – the Pain Barrier - ZOSTRIX is a topical analgesic cream available ...


22 Nov

Banana Boat Dry Balance Sunscreen - NEW Banana Boat Dry Balance Very High ...


22 Nov

Dispensary Corner 22 Nov 17 - A coffee a day keeps heart attack ...


22 Nov

New DDS brand - SIGMA offshoot Discount Drug Stores (DDS) has ...


22 Nov

Clinical Pharmacy Award - DR KAREN Whitfield, team leader specialist pharmacist ...


22 Nov

OTC product for MS - OVER-THE-COUNTER antihistamine clemastine fumarate was shown to ...


22 Nov

Ibuprofen GI impact - GUILD Learning and Development has partnered with ...


22 Nov

SHPA ‘landmark year’ - ACCOLADES and accomplishment denoted last weekend's Society ...


22 Nov

Banana Boat class action - LEGAL firm Bannister Law has confirmed it ...


22 Nov

6CPA RMMR consultation - THE Department of Health has appointed consultancy ...


21 Nov

Guild Update 21 Nov 17: NBN rollout guide for pharmacies - ...


21 Nov

Dispensary Corner 21 Nov 17 - LADIES shopping for makeup, please leave your ...


21 Nov

Creso push into China - LISTED medicinal cannabis company Creso Pharma has ...


21 Nov

MGC aims at epilepsy - MEDICINAL cannabis company MGC Pharmaceuticals has announced ...


21 Nov

Dementia pain app - LISTED Australian company ePAT has developed an ...


21 Nov

GuildCare milestone - GUILDLINK has upgraded more than 1,000 pharmacies ...


21 Nov

Drug PI format shift - THE Therapeutic Goods Administration (TGA) has announced ...


21 Nov

Guild cancels dinner - The Pharmacy Guild has cancelled its annual ...



Show Pharmacy Daily items by month: